AAPL347.68-0.55 (-0.16%) ▼|ABBV285.80+0.61 (+0.21%) ▲|ABT103.70+1.19 (+1.16%) ▲|ACN249.43-9.31 (-3.60%) ▼|ADBE263.82-6.73 (-2.49%) ▼|AMAT377.24+1.66 (+0.44%) ▲|AMD516.79+8.86 (+1.74%) ▲|AMGN439.26-8.02 (-1.79%) ▼|AMT188.97+7.40 (+4.08%) ▲|AMZN248.00-2.38 (-0.95%) ▼|AVGO321.68-1.56 (-0.48%) ▼|AXP313.06-12.11 (-3.72%) ▼|BA188.29+0.74 (+0.39%) ▲|BAC50.57-0.51 (-1.00%) ▼|BKNG155.83-5.27 (-3.27%) ▼|BLK1,117.92-19.37 (-1.70%) ▼|BMY61.48-1.52 (-2.41%) ▼|BNY145.24-0.08 (-0.06%) ▼|BRK-B542.43-4.54 (-0.83%) ▼|C120.67-1.84 (-1.50%) ▼|CAT686.82-17.23 (-2.45%) ▼|CL94.02-3.37 (-3.46%) ▼|CMCSA22.69-0.15 (-0.66%) ▼|COF201.33-2.10 (-1.03%) ▼|COP150.81+5.18 (+3.56%) ▲|COST1,003.32-14.89 (-1.46%) ▼|CRM248.53-1.76 (-0.70%) ▼|CSCO106.50+1.61 (+1.53%) ▲|CVS93.49-0.99 (-1.05%) ▼|CVX233.24+6.56 (+2.89%) ▲|DE646.01+2.39 (+0.37%) ▲|DHR230.50+0.75 (+0.33%) ▲|DIS112.52-0.61 (-0.54%) ▼|DUK124.98-0.42 (-0.33%) ▼|EMR161.59+1.30 (+0.81%) ▲|FDX298.72-5.20 (-1.71%) ▼|GD349.36-1.43 (-0.41%) ▼|GE285.64-7.90 (-2.69%) ▼|GEV815.00-12.42 (-1.50%) ▼|GILD156.04-1.15 (-0.73%) ▼|GM75.92-1.29 (-1.67%) ▼|GOOG317.28-3.48 (-1.08%) ▼|GOOGL320.21-4.01 (-1.24%) ▼|GS875.68-15.62 (-1.75%) ▼|HD319.83-7.90 (-2.41%) ▼|HON221.15+2.84 (+1.30%) ▲|IBM253.56+1.45 (+0.58%) ▲|INTC86.96+1.47 (+1.72%) ▲|INTU343.39-11.51 (-3.24%) ▼|ISRG452.29+8.44 (+1.90%) ▲|JNJ263.81-3.80 (-1.42%) ▼|JPM331.58-4.96 (-1.47%) ▼|KO92.71-2.63 (-2.76%) ▼|LIN508.83-1.53 (-0.30%) ▼|LLY1,273.46-33.23 (-2.54%) ▼|LMT604.18+14.27 (+2.42%) ▲|LOW198.69-5.68 (-2.78%) ▼|LRCX230.10-0.05 (-0.02%) ▼|MA623.60-9.61 (-1.52%) ▼|MCD248.46-4.17 (-1.65%) ▼|MDLZ63.80-1.39 (-2.13%) ▼|MDT95.41-1.18 (-1.22%) ▼|META642.62-6.23 (-0.96%) ▼|MMM173.48-2.08 (-1.18%) ▼|MO74.32-1.75 (-2.30%) ▼|MRK145.25-1.99 (-1.35%) ▼|MS179.48-4.49 (-2.44%) ▼|MSFT524.51+3.43 (+0.66%) ▲|MU877.55+21.06 (+2.46%) ▲|NEE82.10+0.20 (+0.24%) ▲|NFLX65.85-1.20 (-1.79%) ▼|NKE37.30-1.02 (-2.66%) ▼|NOW158.96+1.96 (+1.25%) ▲|NVDA210.96-1.25 (-0.59%) ▼|ORCL126.16+0.62 (+0.49%) ▲|PEP135.77-3.06 (-2.20%) ▼|PFE30.03-0.39 (-1.28%) ▼|PG161.11-3.39 (-2.06%) ▼|PLTR196.75+0.56 (+0.29%) ▲|PM199.47-2.27 (-1.13%) ▼|QCOM175.91+3.08 (+1.78%) ▲|RTX191.01-3.70 (-1.90%) ▼|SBUX100.80-1.11 (-1.09%) ▼|SCHW90.58-0.86 (-0.94%) ▼|SO92.89-0.93 (-0.99%) ▼|SPG211.63-0.41 (-0.19%) ▼|T20.93-1.81 (-7.96%) ▼|TMO673.82-2.72 (-0.40%) ▼|TMUS146.54-12.25 (-7.71%) ▼|TSLA372.22-2.36 (-0.63%) ▼|TXN284.69+5.19 (+1.86%) ▲|UBER66.70-2.37 (-3.43%) ▼|UNH418.09-6.89 (-1.62%) ▼|UNP292.87-5.22 (-1.75%) ▼|UPS101.06-0.46 (-0.45%) ▼|USB59.58-0.44 (-0.73%) ▼|V407.92-6.42 (-1.55%) ▼|VZ44.66-0.54 (-1.19%) ▼|WFC82.39-0.62 (-0.75%) ▼|WMT119.89-1.23 (-1.02%) ▼|XOM183.21+4.98 (+2.79%) ▲|AAPL347.68-0.55 (-0.16%) ▼|ABBV285.80+0.61 (+0.21%) ▲|ABT103.70+1.19 (+1.16%) ▲|ACN249.43-9.31 (-3.60%) ▼|ADBE263.82-6.73 (-2.49%) ▼|AMAT377.24+1.66 (+0.44%) ▲|AMD516.79+8.86 (+1.74%) ▲|AMGN439.26-8.02 (-1.79%) ▼|AMT188.97+7.40 (+4.08%) ▲|AMZN248.00-2.38 (-0.95%) ▼|AVGO321.68-1.56 (-0.48%) ▼|AXP313.06-12.11 (-3.72%) ▼|BA188.29+0.74 (+0.39%) ▲|BAC50.57-0.51 (-1.00%) ▼|BKNG155.83-5.27 (-3.27%) ▼|BLK1,117.92-19.37 (-1.70%) ▼|BMY61.48-1.52 (-2.41%) ▼|BNY145.24-0.08 (-0.06%) ▼|BRK-B542.43-4.54 (-0.83%) ▼|C120.67-1.84 (-1.50%) ▼|CAT686.82-17.23 (-2.45%) ▼|CL94.02-3.37 (-3.46%) ▼|CMCSA22.69-0.15 (-0.66%) ▼|COF201.33-2.10 (-1.03%) ▼|COP150.81+5.18 (+3.56%) ▲|COST1,003.32-14.89 (-1.46%) ▼|CRM248.53-1.76 (-0.70%) ▼|CSCO106.50+1.61 (+1.53%) ▲|CVS93.49-0.99 (-1.05%) ▼|CVX233.24+6.56 (+2.89%) ▲|DE646.01+2.39 (+0.37%) ▲|DHR230.50+0.75 (+0.33%) ▲|DIS112.52-0.61 (-0.54%) ▼|DUK124.98-0.42 (-0.33%) ▼|EMR161.59+1.30 (+0.81%) ▲|FDX298.72-5.20 (-1.71%) ▼|GD349.36-1.43 (-0.41%) ▼|GE285.64-7.90 (-2.69%) ▼|GEV815.00-12.42 (-1.50%) ▼|GILD156.04-1.15 (-0.73%) ▼|GM75.92-1.29 (-1.67%) ▼|GOOG317.28-3.48 (-1.08%) ▼|GOOGL320.21-4.01 (-1.24%) ▼|GS875.68-15.62 (-1.75%) ▼|HD319.83-7.90 (-2.41%) ▼|HON221.15+2.84 (+1.30%) ▲|IBM253.56+1.45 (+0.58%) ▲|INTC86.96+1.47 (+1.72%) ▲|INTU343.39-11.51 (-3.24%) ▼|ISRG452.29+8.44 (+1.90%) ▲|JNJ263.81-3.80 (-1.42%) ▼|JPM331.58-4.96 (-1.47%) ▼|KO92.71-2.63 (-2.76%) ▼|LIN508.83-1.53 (-0.30%) ▼|LLY1,273.46-33.23 (-2.54%) ▼|LMT604.18+14.27 (+2.42%) ▲|LOW198.69-5.68 (-2.78%) ▼|LRCX230.10-0.05 (-0.02%) ▼|MA623.60-9.61 (-1.52%) ▼|MCD248.46-4.17 (-1.65%) ▼|MDLZ63.80-1.39 (-2.13%) ▼|MDT95.41-1.18 (-1.22%) ▼|META642.62-6.23 (-0.96%) ▼|MMM173.48-2.08 (-1.18%) ▼|MO74.32-1.75 (-2.30%) ▼|MRK145.25-1.99 (-1.35%) ▼|MS179.48-4.49 (-2.44%) ▼|MSFT524.51+3.43 (+0.66%) ▲|MU877.55+21.06 (+2.46%) ▲|NEE82.10+0.20 (+0.24%) ▲|NFLX65.85-1.20 (-1.79%) ▼|NKE37.30-1.02 (-2.66%) ▼|NOW158.96+1.96 (+1.25%) ▲|NVDA210.96-1.25 (-0.59%) ▼|ORCL126.16+0.62 (+0.49%) ▲|PEP135.77-3.06 (-2.20%) ▼|PFE30.03-0.39 (-1.28%) ▼|PG161.11-3.39 (-2.06%) ▼|PLTR196.75+0.56 (+0.29%) ▲|PM199.47-2.27 (-1.13%) ▼|QCOM175.91+3.08 (+1.78%) ▲|RTX191.01-3.70 (-1.90%) ▼|SBUX100.80-1.11 (-1.09%) ▼|SCHW90.58-0.86 (-0.94%) ▼|SO92.89-0.93 (-0.99%) ▼|SPG211.63-0.41 (-0.19%) ▼|T20.93-1.81 (-7.96%) ▼|TMO673.82-2.72 (-0.40%) ▼|TMUS146.54-12.25 (-7.71%) ▼|TSLA372.22-2.36 (-0.63%) ▼|TXN284.69+5.19 (+1.86%) ▲|UBER66.70-2.37 (-3.43%) ▼|UNH418.09-6.89 (-1.62%) ▼|UNP292.87-5.22 (-1.75%) ▼|UPS101.06-0.46 (-0.45%) ▼|USB59.58-0.44 (-0.73%) ▼|V407.92-6.42 (-1.55%) ▼|VZ44.66-0.54 (-1.19%) ▼|WFC82.39-0.62 (-0.75%) ▼|WMT119.89-1.23 (-1.02%) ▼|XOM183.21+4.98 (+2.79%) ▲|
15.7 C
New York
Friday, October 23, 2026

Tag: body

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with...

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and AID Use

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Novo Nordisk’s investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes–presented at ADA 2026

A phase 2 study of investigational once-weekly subcutaneous zenagamtide showed statistically significant reductions in blood sugar in adults with type 2 diabetes compared to...

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

Phase 2 Study Results Highlight Use of Once-Daily Injection for Weight Loss and Reduction in Insulin UseNEW ORLEANS, June 5, 2026 /PRNewswire/ -- A...

SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver

Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281VANCOUVER, BC, June 5, 2026 /PRNewswire/ -- Synbio Tech Inc. (SynbioTech),...

Pudu Robotics Unveils PuduFM 1.0 and PuduAgent: Defining the Next Era of Humanoid and Embodied AI Systems

Pudu Robotics launches PuduFM 1.0 & PuduAgent, enabling "One Brain, Multiple Embodiments" for scalable service robots across industries.

In HelloNation, Expert Corporate Wellness Strategist Valarie L. Harris, LPC-MHSP-S, NCC, Highlights the Importance of Pattern Recognition

CLARKSVILLE, Tenn., June 5, 2026 /PRNewswire/ -- What leadership skills are most essential for building healthy and effective teams? In a HelloNation article, Expert...

Popilush Continues Retail Expansion with New Kohl’s Partnership

Viral Shapewear Apparel Brand Joins the Department Store's E-Commerce Platform Reaching Millions of New CustomersNEW YORK, June 5, 2026 /PRNewswire/ -- Popilush, the trailblazing,...

UREVO Debuts Smart Wellness Pop-Up in SoHo

UREVO Debuts Smart Wellness Pop-Up in SoHo--Three-day public experience during New York Tech Week showcases the future of active work and recovery

ALLSWIFIT Launches the Stedi Collection, Reimagining Stability as the Foundation of Everyday Comfort

New performance-lifestyle footwear platform combines adaptive cushioning, biomechanical support, and effortless versatility to help people move confidently through every part of the dayNEW YORK,...

MISOORA Unveils Revolutionary K-Beauty Skincare Range Emphasizing Longevity Over Anti-Aging

A five-step biotech regimen, anchored by NAD+ and Retinaldehyde, opens its founding waitlist ahead of a June 22 US debut.
A five-step biotech regimen, anchored by NAD+ and Retinaldehyde, opens its founding waitlist ahead of a June 22 US debut.

Deutsche Lufthansa AG: Dr Johannes Teyssen, Acquisition

Deutsche Lufthansa AG: Dr Johannes Teyssen, Acquisition

NAVEE Debuts Consumer-Grade Wing-in-Ground Craft with Global Maiden Flight, Expanding Its Mobility Ecosystem

SUZHOU, China, June 5, 2026 /PRNewswire/ -- NAVEE, a global intelligent outdoor mobility brand, debuted the WaveFly 5X, the world's first consumer-grade wing-in-ground (WIG)...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsBody